Avaleht › Crohni tõbi › Texas › Lubbock
Crohni tõbi kliinilised uuringud linnas Lubbock, TX
10 uuringut haiguse Crohni tõbi jaoks otsivad osalejaid linnas Lubbock ja selle ümbruses (umbes 30 miili raadiuses). Avage uuring, et näha, kes saab osaleda ja kuidas võtta ühendust uuringumeeskonnaga.
Ametlik uuringutekst (inglise keeles)
Otsite osalejaid uuringusse? Esitlege seda selle lehe tipus – $99 30 päeva eest →
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
VärbamineFaas 3
- GI Alliance - Lubbock ( Site 0288), Lubbock
- Caprock Gastro Research ( Site 0293), Lubbock
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
VärbamineFaas 3
- Caprock Gastro Research ( Site 5077), Lubbock
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
VärbamineFaas 2
- GI Alliance - Lubbock /ID# 283920, Lubbock
- Caprock Gastro Research - Lubbock /ID# 283921, Lubbock
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
VärbamineFaas 4
- West Texas Research Institute, Lubbock
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
VärbamineFaas 2
- Caprock Gastro Research - Lubbock /ID# 265541, Lubbock
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
VärbamineFaas 3
- Lubbock Gastroenterology, Lubbock
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
VärbamineFaas 3
- GI Alliance - Lubbock-Site Number: 8400092, Lubbock
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
VärbamineFaas 3
- GI Alliance - Lubbock-Site Number: 8400092, Lubbock
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
VärbamineFaas 4
- Texas Digestive Disease Consultants Lubbock, Lubbock
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
VärbamineFaas 2
- Mirador Therapeutics Selected Site, Lubbock
Crohni tõbi uuringud teistes linnades
- New York City, NY35 uuringut
- Cleveland, OH19 uuringut
- St. Louis, MO19 uuringut
- Boston, MA19 uuringut
- Miami, FL19 uuringut
- Orlando, FL17 uuringut
- Houston, TX17 uuringut
- Atlanta, GA17 uuringut
- Tyler, TX16 uuringut
- San Diego, CA15 uuringut
- San Antonio, TX15 uuringut
- Los Angeles, CA15 uuringut
Muud uuringud linnas Lubbock
- Haavandiline koliit9 uuringut
- Rinnavähk6 uuringut
- Mitteväikerakuline kopsuvähk4 uuringut
- Psoriaatiline artriit3 uuringut
- Insult3 uuringut
- Ülekaalulisus3 uuringut
- Rasvumine3 uuringut
- Põletikuline soolehaigus3 uuringut
- Burkitti lümfoom3 uuringut
- Müeloom3 uuringut
Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.